NTLA Delta Exposure (DEX)

Net delta exposure for Intellia Therapeutics Inc (NTLA) options was $21.26M per 1% move at the Nov 4, 2026 close. It has been positive on 20 of the last 20 trading days. Four weeks earlier, on Oct 7, 2026, it was $19.75M.

Upgrade to unlock Call Wall, Put Wall, and multiple expiration dates.

Upgrade now

Delta Exposure by Strike

Showing results for NTLA, 2026-11-20(m), calls & puts

       

Delta Exposure Stats

Showing results for NTLA, 2026-11-20(m), calls & puts



Net Delta Exposure by Expiration

Showing results for NTLA, 2026-11-20(m), calls & puts. View all expiries

       
Expiration Net DEX Call DEX Put DEX Call Wall Put Wall

NTLA Delta Exposure FAQ

What is delta exposure (DEX)?

Delta exposure estimates the dollar value of shares option dealers hold or owe as a hedge, per 1% move in the underlying.

Is NTLA delta exposure positive or negative?

Intellia Therapeutics net delta exposure was positive on Nov 4, 2026, at $21.26M. It has been positive on 20 of the last 20 trading days.

How has NTLA delta exposure changed recently?

Intellia Therapeutics net delta exposure went from $19.75M on Oct 7, 2026 to $21.26M on Nov 4, 2026. See the NTLA delta exposure history for a longer view.

What is Intellia Therapeutics Inc?

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics.

Give feedback on this chart